37
Views
33
CrossRef citations to date
0
Altmetric
Original Article

Naltrexone: A Short-Term Treatment for Opiate Dependence

, , , , , , & show all
Pages 291-300 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Elizabeth Alison Sterner. (2020) Profiles in Science for Science Librarians: A. Thomas McLellan. Science & Technology Libraries 39:4, pages 339-352.
Read now
Paolo Mannelli, Kathleen S Peindl & Li-Tzy Wu. (2011) Pharmacological enhancement of naltrexone treatment for opioid dependence: a review. Substance Abuse and Rehabilitation 2, pages 113-123.
Read now
Angela L Stotts, Carrie L Dodrill & Thomas R Kosten. (2009) Opioid dependence treatment: options in pharmacotherapy. Expert Opinion on Pharmacotherapy 10:11, pages 1727-1740.
Read now
Rose M Etheridge & Robert L Hubbard. (2000) Conceptualizing and Assessing Treatment Structure and Process in Community-Based Drug Dependency Treatment Programs. Substance Use & Misuse 35:12-14, pages 1757-1795.
Read now
Margaret Allison & Robert L. Hubbard. (1985) Drug Abuse Treatment Process: A Review of the Literature. International Journal of the Addictions 20:9, pages 1321-1345.
Read now
Thomas R. Kosten & Herbert D. Kleber. (1984) Strategies to Improve Compliance with Narcotic Antagonists. The American Journal of Drug and Alcohol Abuse 10:2, pages 249-266.
Read now
Edward G. Singleton, Martin F. Sherman & George E. Bigelow. (1984) The Index of Choice: Indications of Methadone Patients' Selection of Naltrexone Treatment. The American Journal of Drug and Alcohol Abuse 10:2, pages 209-221.
Read now

Articles from other publishers (26)

Elyssa B. Margolis, Madelyn G. Moulton, Philip S. Lambeth & Matthew J. O'Meara. (2023) The life and times of endogenous opioid peptides: Updated understanding of synthesis, spatiotemporal dynamics, and the clinical impact in alcohol use disorder. Neuropharmacology 225, pages 109376.
Crossref
Sharon L Smith, Reginald L Dean, Mark S Todtenkopf & David J Heal. (2019) Investigation of the reinforcing potential of samidorphan and naltrexone by fixed and progressive ratio intravenous self-administration testing in heroin-maintained rats. Journal of Psychopharmacology 33:3, pages 383-391.
Crossref
Nowsheen Goonoo, Archana Bhaw-Luximon, Reetesh Ujoodha, Anil Jhugroo, Gary K. Hulse & Dhanjay Jhurry. (2014) Naltrexone: A review of existing sustained drug delivery systems and emerging nano-based systems. Journal of Controlled Release 183, pages 154-166.
Crossref
Reginald L. Dean, David Eyerman, Mark S. Todtenkopf, Ryan Z. Turncliff, Jean M. Bidlack & Daniel R. Deaver. (2012) Effects of oral loperamide on efficacy of naltrexone, baclofen and AM-251 in blocking ethanol self-administration in rats. Pharmacology Biochemistry and Behavior 100:3, pages 530-537.
Crossref
Kimberly L. KjomeF. Gerard Moeller. (2011) Long-Acting Injectable naltrexone for the Management of patients with Opioid Dependence. Substance Abuse: Research and Treatment 5, pages SART.S5452.
Crossref
Allan J. Goodman, Bertrand Le Bourdonnec & Roland E. Dolle. (2007) Mu Opioid Receptor Antagonists: Recent Developments. ChemMedChem 2:11, pages 1552-1570.
Crossref
Paolo Mannelli, Ashwin A. Patkar, Kathleen Peindl, Heather W. Murray, Li-Tzy Wu & Robert Hubbard. (2007) Effectiveness of Low-Dose Naltrexone in the Post-Detoxification Treatment of Opioid Dependence. Journal of Clinical Psychopharmacology 27:5, pages 468-474.
Crossref
Hannah K. Knudsen, Lori J. Ducharme & Paul M. Roman. (2007) The adoption of medications in substance abuse treatment: Associations with organizational characteristics and technology clusters. Drug and Alcohol Dependence 87:2-3, pages 164-174.
Crossref
John Grabowski, Howard Rhoades, Angela Stotts, Katherine Cowan, Charles Kopecky, Anne Dougherty, F Gerard Moeller, Sohela Hassan & Joy Schmitz. (2003) Agonist-Like or Antagonist-Like Treatment for Cocaine Dependence with Methadone for Heroin Dependence: Two Double-Blind Randomized Clinical Trials. Neuropsychopharmacology 29:5, pages 969-981.
Crossref
Richard J. Rosenthal. (2004) The role of medication in the treatment of pathological gambling: Bridging the gap between research and practice. Journal of Gambling Issues:10.
Crossref
Michael P Bogenschutz & Cynthia M.A Geppert. (2003) Pharmacologic treatments for women with addictions. Obstetrics and Gynecology Clinics of North America 30:3, pages 523-544.
Crossref
ANNE BARTU, NERELIE C. FREEMAN, GEOFF S. GAWTHORNE, STEVE J. ALLSOP & ALLAN J. QUIGLEY. (2009) Characteristics, retention and readmissions of opioid‐dependent clients treated with oral naltrexone. Drug and Alcohol Review 21:4, pages 335-340.
Crossref
Jami L Rothenberg, Maria A Sullivan, Sarah H Church, Angela Seracini, Eric Collins, Herbert D Kleber & Edward V Nunes. (2002) Behavioral naltrexone therapy. Journal of Substance Abuse Treatment 23:4, pages 351-360.
Crossref
Catherine McGregor, Robert Ali, Jason M White, Peter Thomas & Linda Gowing. (2002) A comparison of antagonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months. Drug and Alcohol Dependence 68:1, pages 5-14.
Crossref
Vania Modesto-Lowe & Jeffrey Van Kirk. (2002) Clinical uses of naltrexone: A review of the evidence.. Experimental and Clinical Psychopharmacology 10:3, pages 213-227.
Crossref
Jody L SindelarDavid A Fiellin. (2001) Innovations in Treatment for Drug Abuse: Solutions to a Public Health Problem. Annual Review of Public Health 22:1, pages 249-272.
Crossref
Marc A. SchuckitMarc A. Schuckit. 2000. Drug and Alcohol Abuse. Drug and Alcohol Abuse 305 348 .
Marc A. SchuckitMarc A. Schuckit. 1995. Drug and Alcohol Abuse. Drug and Alcohol Abuse 303 349 .
Emi N. Shufman, Shai Porat, Eliezer Witztum, Dan Gandacu, Rachel Bar-Hamburger & Yigal Ginath. (1994) The efficacy of naltrexone in preventing reabuse of heroin after detoxification. Biological Psychiatry 35:12, pages 935-945.
Crossref
Marc A. SchuckitMarc A. Schuckit. 1989. Drug and Alcohol Abuse. Drug and Alcohol Abuse 256 292 .
D. Ladewig. 1987. Abhängigkeit und Sucht. Abhängigkeit und Sucht 359 397 .
Carolyn Grey, Elizabeth Osborn & Marvin Reznikoff. (1986) Psychosocial factors in outcome in two opiate addiction treatments. Journal of Clinical Psychology 42:1, pages 185-189.
Crossref
Barbara A. Judson & Avram Goldstein. (1984) Naltrexone treatment of heroin addiction: One-year follow-up. Drug and Alcohol Dependence 13:4, pages 357-365.
Crossref
Marc A. SchuckitMarc A. Schuckit. 1984. Drug and Alcohol Abuse. Drug and Alcohol Abuse 228 253 .
Robert A. Greenstein, Bradley D. Evans, A.Thomas Mclellan & Charles P. O'Brien. (1983) Predictors of favorable outcome following naltrexone treatment. Drug and Alcohol Dependence 12:2, pages 173-180.
Crossref
Robert E. Willette. (1982) Narcotic Antagonists An Alternative for Treating Opioid Dependence. American Pharmacy 22:8, pages 44-46.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.